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Abstract: Positron Emission Tomography (PET) with F-18-fluoro-
deoxyglucose is commonly used in the evaluation of lung nodules;
however, there is limited data on the PET appearance of coal
worker’s pneumoconiosis (CWP) and its utility for diagnosing lung
malignancy in this setting. Six cases of CWP and suspected malig-
nancy are reported. Each patient had at least one nodule 1 cm in
diameter for a total of 19 nodules1 cm. On PET imaging 18 of the
19 nodules were hypermetabolic and five of the six patients had at
least one nodule that was PET positive. Based on pathologic data
and clinical follow-up, none of the six patients had any evidence of
malignancy. In this series, PET imaging was often positive in
patents with CWP; however, all were false positives with standard-
ized uptake value measurements in the range that are typically seen
with malignant nodules. Due to its high rate of false positives, PET
imaging seems to be of limited utility in diagnosing malignancy in
patients with underlying coal worker’s pneumoconiosis.
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Coal worker’s pneumoconiosis (CWP) results fromchronic exposure to coal dust. On imaging “simple”
CWP is characterized by small (1 cm) nodules with an
upper lobe predominance. Coalescence or conglomeration of
these small nodules to form larger opacities (1 cm) defines
“complicated” CWP, and as these nodules continue to grow
the term “progressive massive fibrosis” (PMF) is often used.
It is these larger nodules seen in complicated CWP/PMF that
sometimes raise the concern for malignancy and can present
a diagnostic dilemma.
Although F-18-fluorodeoxyglucose positron emission
tomography (FDG PET) imaging has gained widespread use
in the diagnosis and staging of lung cancer,1 there is limited
data on the PET appearance of CWP and its utility for
diagnosing lung malignancy in this setting. This report de-
scribes six patients with complicated CWP/PMF and sus-
pected malignancy.
PATIENTS AND METHODS
The medical records of the Multidisciplinary Lung
Cancer Clinic at the University of Kentucky were searched
for cases of suspected lung malignancy and CWP seen
between 2004 and 2007. Six patients were identified and the
results of FDG-PET imaging were reviewed. Three patients
had a PET/(computed tomography) CT fusion examination,
and three patients had PET only. All PET images were
obtained after a 60 minutes incubation period of the FDG. In
each patient the number of nodules 1 cm in diameter was
assessed and all nodules with a standardized uptake value
(SUV, calculated as maximum glucose activity in the lesion/
injected glucose dose/body weight in kilograms) 2.5 on
PET imaging were considered highly suspicious or “positive”
for malignancy. PET results were compared with pathologic
data and clinical follow-up.
Case 1
A 60-year-old man, nonsmoker had worked as a driller
in a coal mine for over 30 years. He was referred to the
thoracic oncology clinic for evaluation of multiple pulmonary
nodules which had been identified on chest radiograph and
confirmed with CT imaging. Seven nodules greater than 1 cm
in diameter were identified. PET imaging demonstrated in-
creased uptake in all seven nodules (SUV: 2.8–4.0) (Figure 1).
The patient had a video-assisted thoracoscopic surgery biopsy
of the right upper lobe which revealed anthracosilicotic nod-
ules. Follow-up chest CT 1 year later showed no change in
the remaining nodules.
Case 2
A 52-year-old man who had been a coal miner for 29
years was referred to the thoracic oncology clinic due to a
history of melanoma and multiple pulmonary nodules on
chest imaging. At the time of presentation, he was a current
smoker with a 40 pack year history. He had a history of a
melanoma (Clark level 2) removed from his right thigh
several years earlier. CT demonstrated many subpleural pul-
monary nodules and mediastinal adenopathy. Only one nod-
ule was greater than 1 cm in diameter, and none of the
nodules demonstrated increased uptake on PET imaging. The
patient had an open lung wedge biopsy performed which
showed anthracosilocotic nodules.
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Case 3
A 54-year-old man, former 20 pack year smoker, un-
derwent an evaluation for upper lobe pulmonary nodules with
associated borderline mediastinal adenopathy on CT chest.
The patient had worked as a coal miner for 20 years. There
were two nodules, one in each upper lobe, both greater than
1 cm in diameter. Both nodules were positive on PET scan
(SUV: 5.3 and 7.2). CT guided core biopsy of the right upper
lobe nodule (Figure 2) demonstrated anthracosilicosis with no
evidence of malignancy. Follow-up CT performed 1 year after
the core biopsy demonstrated a stable appearance of the nodules.
Case 4
A 67-year-old male smoker with history of esophageal
carcinoma was referred for evaluation of multiple upper lobe
pulmonary nodules. He had previously worked as a coal
miner for 15 years, and was a current smoker with a 100 pack
year smoking history. Three years earlier he had been diag-
nosed with esophageal carcinoma and treated with chemo-
therapy, radiation, and an esophagectomy. Approximately 3
years after treatment, a CT scan suggested the progression of
multiple, previously noted, upper lobe pulmonary nodules.
PET imaging revealed multiple positive areas which prompted
his referral. He went on to have a bronchoscopy with transbron-
chial biopsies which demonstrated anthracosilicosis with no
evidence of malignancy. He was subsequently followed for
additional 2 years with serial CT scans demonstrating a stable
appearance in the upper lobe nodules.
Case 5
A 65-year-old male nonsmoker with a history of coal
mining presented for evaluation of multiple pulmonary nod-
ules. CT of the chest revealed multiple nodules with one
nodule greater than 1 cm located in the right lower lobe. PET
scan was performed and there was increased uptake in the
right upper and lower lobes, as well as, multiple areas in the
mediastinum. The most significant uptake was identified in
the right lower lobe nodule (SUV: 15). A CT guided needle
biopsy of the right lower lobe nodule was nondiagnostic. This
was followed by a mediastinoscopy with all surgical speci-
mens demonstrating anthracosilicosis. The patient subse-
quently underwent a right upper lobe wedge resection and
right lower lobectomy. All surgical specimens demonstrated
anthracosilicotic nodules with no evidence of malignancy.
Case 6
A 66-year-old male nonsmoker was referred for eval-
uation of multiple pulmonary nodules and a positive PET
scan. He had worked as a coal miner for more than 20 years.
His CT imaging revealed two nodules greater than 1 cm in
diameter with one in each upper lobe. PET imaging demon-
strated increased uptake in both nodules with the highest
uptake noted in the right upper lobe nodule (SUV: 11.9).
Review of outside records revealed a right upper lobe wedge
biopsy had been performed 4 years earlier and had shown
anthracosilicotic nodules. This patient has been subsequently
followed for an additional 3 years with serial CT scan
demonstrating a stable appearance of the pulmonary nodules.
RESULTS
In this series, six patients had a total of 19 nodules 1
cm in diameter seen on CT (Table 1). Fifteen of 19 nodules
were located in the upper lobes and the mean nodule diameter
for those nodules greater than 1 cm was 1.37 cm (1.0–2.6
cm). Eighteen of the 19 (95%) nodules were positive (SUV
FIGURE 1. Case 1, (left panel)
computed tomography (CT) scan
showing a 1.3 cm nodule in the
right upper lobe. (Right panel), The
corresponding positron emission
tomography (PET) axial view shows
a hypermetabolic lesion (arrow)
with an standardized uptake value
(SUV) of 4.0. Video-assisted thora-
coscopic surgery (VATS) biopsy
revealed anthracosilicotic nodules.
FIGURE 2. Case 3, (left panel)
computed tomography (CT) scan
showing a 1.1 cm nodule in the
right upper lobe. (Right panel) The
corresponding positron emission
tomography (PET) axial view shows
a hypermetabolic lesion (arrow) with
an standardized uptake value (SUV)
of 5.3. Core needle biopsy revealed
anthracosilicosis without evidence of
malignancy.
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2.5) on PET with a mean SUV of 6.0 (2.8–15). Five of the
6 patients (83%) had at least one nodule that was PET
positive; however, all 5 had histologic evidence of anthraco-
silicosis without malignancy and none have developed ma-
lignancy during follow-up. All PET positive nodules were
false positives with SUV measurements in the range that is
typically seen with malignant nodules. The size of the nodule
relative to the degree of hypermetabolism did not seem to be
helpful in distinguishing benign from malignant, in fact, the
nodule with highest SUV of 15 measured only 1.6 cm in
diameter.
DISCUSSION
Patients with complicated CWP/PMF and concern for
coexisting lung malignancy can present a diagnostic dilemma
for the pulmonary physician. It is often difficult or impossible
to distinguish CWP/PMF lesions from bronchogenic carci-
noma based on radiographic findings alone. PET imaging is
often recommended in the evaluation of pulmonary nodules1;
however, the literature on the utility of PET for the diagnosis
of malignancy in the setting of CWP is limited.
In patients with CWP/PMF without malignancy, hyper-
metabolic lesions on PET imaging have been described.2,3
These reports are few, so the prevalence and the degree of
hypermetabolism seen on PET imaging in patients with
CWP/PMF have not been well characterized. In the setting of
CWP/PMF and suspected lung cancer there are few reports to
guide the use of PET imaging. Two single case reports have
suggested that PET imaging might be useful in the diagnosis
of malignancy in patients with CWP/PMF,4,5 although an-
other small study suggested that the degree of uptake relative
to the size of the nodule might be helpful in distinguishing
benign from malignant nodules (e.g., smaller nodules with
higher uptake would be more likely to be malignant).6
In our series of six patients with CWP, pulmonary
nodules 1 cm in diameter frequently demonstrated in-
creased uptake on PET imaging with SUV values in the
malignant range. All PET positives nodules were false posi-
tives and the degree of uptake relative to the size of the
nodule did not appear helpful in differentiating benign from
malignant. In clinical practice, nodules with SUV 2.5 on
PET imaging are considered highly suspicious for malig-
nancy and will usually have a needle biopsy or surgical
biopsy performed. Based on our series, following this ap-
proach for patients with CWP/PMF would lead to many
unnecessary invasive procedures in patients with benign le-
sions. Although PET imaging is useful for the evaluation of
pulmonary nodules in the general population, it seems to be
of limited utility in diagnosing malignancy in patients with
complicated CWP/PMF due to the high rate of false positives
demonstrated in this series. Careful follow-up with serial CT
imaging may be the most appropriate approach in many of
these patients with invasive procedures being reserved for
those that show nodule growth.
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TABLE 1. PET Imaging Results for Nodules Greater Than
1 cm in Diameter in Six Patients with Coal Worker’s
Pneumoconiosis and Suspected Malignancy
Case
No.
Nodules >1 cm
(n  19)
Nodules >1cm,
Range in
Size (cm)
PET Positive
Nodules
(SUV >2.5)
SUV
Range
1 7 1–1.5 7 2.8–4.0
2 1 1 0 —
3 2 1–1.2 2 5.3–7.2
4 6 1.3–2.0 6 4.9–5.7
5 1 1.6 1 15.0
6 2 1.5–2.6 2 11.9a
a Only the nodule with the highest SUV was reported.
PET, positron emission tomography; SUV, standardized uptake value.
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